Please login to the form below

Not currently logged in
Email:
Password:

J&J appoints Bayer’s Sandra Peterson as group worldwide chair

Will have responsibility for troubled consumer goods division

J&J - Sandra PetersonSandra Peterson is to leave her role as chair and CEO of Bayer CropScience to join Johnson & Johnson (J&J) as its group worldwide chair.

Joining J&J on December 1, 2012, Peterson will have responsibility for J&J's IT and global supply chain, as well as its troubled consumer division, which has been beset by recalls and quality control problems these past two years.

The appointment is the first major executive change at J&J since Alex Gorsky became CEO in April, 2012, and he gave his thoughts on what Peterson could bring to such a high profile role.

“Sandi Peterson is an experienced global leader known for her strategic thinking and proven track record in growing businesses,” he said.

“She brings 25 years of experience to her new role, which will draw on her expertise in building fully integrated global businesses, and focusing on growth.”

Peterson has held her current role at Bayer since 2010, having previously served as president and CEO of Bayer Medical Care and president of Bayer HealthCare AG's Diabetes Care Division.

Prior to joining Bayer in 2005, Peterson spent five years in leadership roles at Medco Health Solutions following a series of positions at Nabisco, Whirlpool Corporation and McKinsey & Company.

“With her experience and commitment, Sandi has made significant contributions to the strong business performance of Bayer CropScience in the past two years,” said Dr Marijn Dekkers, CEO of Bayer.

“However, we accept her decision to continue her career back in her home country of the US and wish her all the best for the future.”

18th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Easier access to medicines in the UK?
Cutting through the NICE value-based assessment consultation to find out what’s at stake...
Exploring MINT: Part 3 - Nigeria
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria....
BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....